Continuous Glucose Monitor

Abbott announced that the FDA has removed the contraindication for its continuous glucose monitoring sensors to be used during imaging procedures.

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

One of many challenges parents face when their child is diagnosed with diabetes is how the condition will be managed in school, particularly if the child is using a diabetes device.

Drinking caffeinated beverages as an adult may lower the risk for developing multiple cardiometabolic diseases compared with adults who do not consume caffeine, according to study findings.

In patients with basal insulin-treated type 2 diabetes, sotagliflozin was associated with greater time in range compared with placebo at 18 weeks, researchers reported at the European Association for the Study of Diabetes Annual Meeting.

The FDA has cleared a continuous glucose monitoring system with an implantable sensor that can be worn for up to 1 year for adults aged 18 years and older with type 1 or type 2 diabetes, according to a press release.

The FDA has cleared a tubeless automated insulin delivery system indicated for adults with type 2 diabetes.

Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.

Women with fetal overgrowth or hypertensive disorders of pregnancy have notable continuous glucose monitor-derived glycemic patterns detected during early pregnancy, sometimes without a gestational diabetes diagnosis, researchers reported.

Primary care practices can successfully implement continuous glucose monitoring for patients with diabetes by using American Academy of Family Physicians resources or a virtual CGM initiation service, according to two speakers.